172 related articles for article (PubMed ID: 25041341)
1. Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment.
Song H; Shi H; Zhang X; Wang J; Yu Y; Chen W; Zhou H
Br J Dermatol; 2015 Feb; 172(2):444-9. PubMed ID: 25041341
[TBL] [Abstract][Full Text] [Related]
2. Low-dose propranolol regimen for infantile haemangioma.
Tan CE; Itinteang T; Leadbitter P; Marsh R; Tan ST
J Paediatr Child Health; 2015 Apr; 51(4):419-24. PubMed ID: 25187156
[TBL] [Abstract][Full Text] [Related]
3. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
4. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
5. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
6. Evidence and nuances of propranolol safety.
Püttgen KB
Br J Dermatol; 2015 Feb; 172(2):319-20. PubMed ID: 25660680
[No Abstract] [Full Text] [Related]
7. Propranolol for infantile haemangioma: striking effect in the first weeks.
Katona G; Csákányi Z; Gács E; Szalai Z; Ráth G; Gerlinger I
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1746-50. PubMed ID: 22944359
[TBL] [Abstract][Full Text] [Related]
8. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
9. Low-dose propranolol for infantile haemangioma.
Tan ST; Itinteang T; Leadbitter P
J Plast Reconstr Aesthet Surg; 2011 Mar; 64(3):292-9. PubMed ID: 20615772
[TBL] [Abstract][Full Text] [Related]
10. Use of propranolol in infantile haemangioma among Chinese children.
Chik KK; Luk CK; Chan HB; Tan HY
Hong Kong Med J; 2010 Oct; 16(5):341-6. PubMed ID: 20889997
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of propranolol for cutaneous hemangiomas in premature children.
Brazzelli V; Giorgini C; Barruscotti S; Codazzi CA; Mannarino S; Tzialla C; Stronati M; Marseglia GL; Borroni G
G Ital Dermatol Venereol; 2016 Oct; 151(5):485-91. PubMed ID: 25692776
[TBL] [Abstract][Full Text] [Related]
12. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
13. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
14. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
15. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
Li XY; Wang Y; Jin L; Chen JR
Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
[TBL] [Abstract][Full Text] [Related]
16. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
17. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
Breur JM; de Graaf M; Breugem CC; Pasmans SG
Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infantile hemangiomas: therapeutic options in regard to side effects and adverse events - a review of the literature.
Raphael MF; Breur JM; Vlasveld FA; Elbert NJ; Liem YT; Kon M; Breugem CC; Pasmans SG
Expert Opin Drug Saf; 2016; 15(2):199-214. PubMed ID: 26646657
[TBL] [Abstract][Full Text] [Related]
20. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]